Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Capasso

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
European Journal of Pediatrics|April 18, 2024
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?Marika Pane, Giulia Stanca, Chiara Ticci, et al.
Eclinicalmedicine|May 21, 2026
The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single <i>SMN2</i> copy: an international retrospective observational studyGianpaolo Cicala, Anna Capasso, Marianna Villa, et al.
Eclinicalmedicine|May 17, 2023
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapiesMarika Pane, Beatrice Berti, Anna Capasso, et al.
Journal of Neuromuscular Diseases|September 18, 2025
Upper limb progression in Duchenne muscular dystrophy: Insights from a 36-month longitudinal study using the PUL 20Giorgia Coratti, Marika Pane, Sophia Paolucci, et al.
Annals of Neurology|September 11, 2023
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?Martina Ricci, Gianpaolo Cicala, Anna Capasso, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
Journal of Neuromuscular Diseases|April 17, 2023
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?Marika Pane, Giorgia Coratti, Claudia Brogna, et al.
Neurology|December 2, 2022
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide SurveyGiorgia Coratti, Martina Ricci, Anna Capasso, et al.
European Journal of Pediatrics|December 16, 2024
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide surveyAnna Capasso, Gianpaolo Cicala, Martina Ricci, et al.
Neuromuscular Disorders : NMD|December 29, 2023
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month studyGiorgia Coratti, Marika Pane, Claudia Brogna, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
European Journal of Pediatrics|April 18, 2024
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?Marika Pane, Giulia Stanca, Chiara Ticci, et al.
Eclinicalmedicine|May 21, 2026
The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single <i>SMN2</i> copy: an international retrospective observational studyGianpaolo Cicala, Anna Capasso, Marianna Villa, et al.
Eclinicalmedicine|May 17, 2023
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapiesMarika Pane, Beatrice Berti, Anna Capasso, et al.
Journal of Neuromuscular Diseases|September 18, 2025
Upper limb progression in Duchenne muscular dystrophy: Insights from a 36-month longitudinal study using the PUL 20Giorgia Coratti, Marika Pane, Sophia Paolucci, et al.
Annals of Neurology|September 11, 2023
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?Martina Ricci, Gianpaolo Cicala, Anna Capasso, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
Journal of Neuromuscular Diseases|April 17, 2023
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?Marika Pane, Giorgia Coratti, Claudia Brogna, et al.
Neurology|December 2, 2022
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide SurveyGiorgia Coratti, Martina Ricci, Anna Capasso, et al.
European Journal of Pediatrics|December 16, 2024
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide surveyAnna Capasso, Gianpaolo Cicala, Martina Ricci, et al.
Neuromuscular Disorders : NMD|December 29, 2023
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month studyGiorgia Coratti, Marika Pane, Claudia Brogna, et al.
Pageof 17